CIK 0001527753 · Non-accelerated filer<br>Smaller reporting company
Personalis, Inc.
Sign in to watch- Ticker
- PSNL
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275411038
- Phone
- 650-752-1300
- Business address
- 6600 DUMBARTON CIRCLE, FREMONT, CA, 94555
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $728,924
- in 5 filings
Net −$728,924. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-12 | MYERS WOODROW A JR Director | Grant or award | +6,250 | 32,366 | ||
| 2026-05-12 | MYERS WOODROW A JR Director | Grant or award · Stock Option (right to buy) | +37,500 | 37,500 | ||
| 2026-05-12 | EASTHAM KARIN Director | Grant or award | +6,250 | 22,366 | ||
| 2026-05-12 | EASTHAM KARIN Director | Grant or award · Stock Option (right to buy) | +37,500 | 37,500 | ||
| 2026-05-12 | WIDDER KENNETH J Director | Grant or award | +6,250 | 6,250 | ||
| 2026-05-12 | WIDDER KENNETH J Director | Grant or award · Stock Option (right to buy) | +37,500 | 37,500 | ||
| 2026-05-12 | BOWMAN A BLAINE Director | Grant or award | +6,250 | 19,756 | ||
| 2026-05-12 | BOWMAN A BLAINE Director | Grant or award · Stock Option (right to buy) | +37,500 | 37,500 | ||
| 2026-03-15 | Moore Stephen Michael SVP and Chief Legal Officer | Grant or award | +28,125 | 92,325 | ||
| 2026-03-15 | Moore Stephen Michael SVP and Chief Legal Officer | Grant or award · Stock Option (right to buy) | +168,750 | 168,750 | ||
| 2026-03-15 | Chen Richard President and CMO | Grant or award | +46,875 | 173,880 | ||
| 2026-03-15 | Chen Richard President and CMO | Grant or award · Stock Option (right to buy) | +281,250 | 281,250 | ||
| 2026-03-15 | Hall Christopher M Chief Executive Officer | Grant or award | +87,500 | 235,986 | ||
| 2026-03-15 | Hall Christopher M Chief Executive Officer | Grant or award · Stock Option (right to buy) | +525,000 | 525,000 | ||
| 2026-03-15 | Tachibana Aaron CFO AND COO | Grant or award | +34,375 | 198,833 | ||
| 2026-03-15 | Tachibana Aaron CFO AND COO | Grant or award · Stock Option (right to buy) | +206,250 | 206,250 | ||
| 2026-02-23 | Moore Stephen Michael SVP and Chief Legal Officer | Grant or award · Stock Option (right to buy) | +8,333 | 8,333 | ||
| 2026-02-23 | Chen Richard CHIEF MEDICAL OFFICER AND EVP | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 | ||
| 2026-02-23 | Hall Christopher M PRESIDENT AND CEO | Grant or award · Stock Option (right to buy) | +33,333 | 33,333 | ||
| 2026-02-23 | Tachibana Aaron CFO AND COO | Grant or award · Stock Option (right to buy) | +15,000 | 15,000 |
Page 3 of 23 · 444 trades